Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 104
interventional 89
Observational 13
Registry 2

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 30
Drug|placebo 24
Other 7
Dietary Supplement|placebo 5
Device 4
Device|Drug 3
Drug|Other 3
Behavioral 2
Dietary Supplement 2
Procedure 2
Biological 1
Biological|Drug 1
Biological|Drug|Other 1
Biological|Drug|placebo 1
Biological|placebo 1
Other|placebo 1
placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 35
NA 9
Canada 4
France 4
China 3
Kenya 3
Germany 2
Israel 2
Spain 2
Zambia 2
Belgium 1
Belgium|Czech Republic|Germany|Slovakia|Switzerland 1
Brazil 1
Czechia 1
Ethiopia 1
Ghana|Guinea|Togo 1
India 1
Nigeria 1
Norway 1
Romania 1
Rwanda 1
Sweden 1
Switzerland 1
Taiwan 1
Tanzania 1
Turkey 1
Uganda 1
Ukraine 1
United Kingdom 1
United States|Bulgaria|Czechia|Hungary|Ukraine|United Kingdom 1
United States|Canada|Puerto Rico 1
United States|Dominican Republic|Puerto Rico 1
United States|Kenya 1

Sites per Study

Site_count Study_Count
1 60
2 6
3 2
4 2
5 1
6 1
7 2
8 2
11 1
13 1
14 2
16 1
18 1
20 1
21 1
30 1
37 2
40 1
45 1

Phase

Phase Study_Count
N/A 26
Phase 4 19
Phase 3 18
Phase 2 13
Phase 1 5
Early Phase 1 3
Phase 2/Phase 3 3
Phase 1/Phase 2 2

Number of Arms

Number_of_Arms Count_of_Studies
1 15
2 53
3 8
4 6
NA 7

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 14.0 7.0000 6.0 126.00 40.0000 13.0000 99.0000 12.0000
1st Qu. 22.0 40.7500 12.0 239.25 106.0000 81.5000 250.0000 55.0000
Median 30.0 64.0000 50.0 352.50 132.0000 150.0000 352.0000 116.0000
Mean 27.0 201.2308 134.6 352.50 160.2308 115.6667 816.4706 392.3684
3rd Qu. 33.5 224.5000 80.0 465.75 228.0000 167.0000 651.0000 245.0000
Max. 37.0 1049.0000 525.0 579.00 255.0000 184.0000 5436.0000 3105.0000

Trial Group Type

group_type Group_Count
Experimental 69
Active Comparator 46
Placebo Comparator 39
Other 9
NA 7
No Intervention 5
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Parallel Assignment 64
Single Group Assignment 22
Crossover Assignment 2
Factorial Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 47
Prevention 28
Supportive Care 4
NA 4
Basic Science 3
Diagnostic 2
Screening 1

Observational Studies

Studies by Country

Country Study_Count
NA 3
United States 3
Austria 1
Canada 1
Denmark 1
Kazakhstan 1
Pakistan 1
Rwanda 1
Sweden 1

Sites per Study

Site_count Study_Count
1 13

Enrollment Metrics

Measure Observational
Min 42.000
1st Qu 195.000
Median 400.000
Mean 1397.231
3rd Qu 540.000
Max 13024.000

Observation Model

observational_model Study_Count
Cohort 8
Other 2
Case-Control 1
Case-Only 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 9
Cross-Sectional 2
Retrospective 1
NA 1

Registries

Studies by Country

Country Study_Count
Sweden 1
United States 1

Sites per Study

Site_count Study_Count
1 1
2 1

Enrollment Metrics

Measure Registries
Min 50
1st Qu 175
Median 300
Mean 300
3rd Qu 425
Max 550

Registry Model

observational_model Study_Count
Case-Only 1
Cohort 1

Time Perspective

time_perspective Study_Count
Prospective 2

Follow-up

target_duration Study_Count
12 Months 1
6 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03187457 PreFem: “What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?” https://ClinicalTrials.gov/show/NCT03187457 Completed Danisco 2017-11-14
NCT03134924 Vaginal Practices in Human Immunodeficiency Virus (HIV) Positive Women in Zambia, a Bio-Behavioral Intervention “WASH-2” https://ClinicalTrials.gov/show/NCT03134924 Completed University of Miami 2014-02-05
NCT03116789 Analysis of Ameliorative Effects of Oral Probiotics on Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT03116789 Completed GenMont Biotech Incorporation 2019-12-31
NCT03099408 Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent Recurrence of Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT03099408 Recruiting Peking University Shenzhen Hospital 2020-12-30
NCT03091777 Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT03091777 Completed Gage Development Company, LLC 2017-11-15
NCT02946346 Kinetics and Ecology of Human Papillomavirus Genital Infections in Young Women https://ClinicalTrials.gov/show/NCT02946346 Recruiting University Hospital, Montpellier 2021-09-30
NCT02905890 The Effect of Norethisterone Enanthate on Recurrent Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT02905890 Completed London School of Hygiene and Tropical Medicine 2019-12-20
NCT02866227 TOL-463 Phase 2 Study for Vaginitis https://ClinicalTrials.gov/show/NCT02866227 Completed Toltec Pharmaceuticals, LLC 2017-06-10
NCT02863536 A Study of the New Medical Device Polybactum® https://ClinicalTrials.gov/show/NCT02863536 Completed Effik Italia S.p.A. 2018-08-01
NCT02860845 Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections https://ClinicalTrials.gov/show/NCT02860845 Completed Laboratorios Ordesa 2017-10-16
NCT02795845 Oral Probiotics for the Treatment and Prevention of Vulvovaginal Infections in Pregnancy - Double-blind, Randomized, Placebo-controlled Study https://ClinicalTrials.gov/show/NCT02795845 Recruiting HaEmek Medical Center, Israel 2021-07-31
NCT02766023 LACTIN-V Study for Recurrent Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT02766023 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2019-02-11
NCT02744638 Effect of a Yoghurt Containing Four Probiotic Lactobacillus Strains on Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT02744638 Completed Clinical Research Center Kiel GmbH 2016-08-31
NCT02709005 Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT02709005 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2017-12-11
NCT02687789 Safety, Tolerability and Efficacy of Vaginal Suppository WO3191 in the Post-treatment of Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT02687789 Completed Dr. August Wolff GmbH & Co. KG Arzneimittel 2015-07-31
NCT02042287 Treatment Comparison of Antibiotics Versus Vaginal Lactic Acid in Non-pregnant Women With Acute Symptomatic Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT02042287 Recruiting University Hospital Inselspital, Berne 2021-12-31
NCT02527941 Effect of Bacterial Vaginosis on HIV Susceptibility and Female Genital Immunology https://ClinicalTrials.gov/show/NCT02527941 Completed University of Toronto 2015-11-30
NCT02459665 Rwanda Vaginal Microbiota Restoration Study https://ClinicalTrials.gov/show/NCT02459665 Completed University of Liverpool 2016-02-23
NCT02452866 Open-Label Study to Evaluate the Safety of A Single Dose of SYM-1219, a Granule Formulation Containing 2 Grams of Secnidazole https://ClinicalTrials.gov/show/NCT02452866 Completed Symbiomix Therapeutics 2015-10-31
NCT02445989 Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity https://ClinicalTrials.gov/show/NCT02445989 Completed University of Washington 2018-11-30
NCT02432404 Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity https://ClinicalTrials.gov/show/NCT02432404 Active, not recruiting University of Washington 2020-07-31
NCT02418845 A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT02418845 Completed Symbiomix Therapeutics 2015-10-31
NCT02392026 Safety and Tolerability of Metronidazole Gel 1.3% https://ClinicalTrials.gov/show/NCT02392026 Completed Insud Pharma 2016-10-31
NCT02314429 Trial Evaluating the Safety of a Lactate Releasing Vaginal Ring for the Prophylaxis of Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT02314429 Completed University Hospital, Ghent 2015-01-31
NCT02237950 Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV) https://ClinicalTrials.gov/show/NCT02237950 Completed Starpharma Pty Ltd 2016-12-09
NCT02236429 Vaginal Flora for Treatment of Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT02236429 Recruiting Hadassah Medical Organization 2020-03-31
NCT02236156 Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV) https://ClinicalTrials.gov/show/NCT02236156 Completed Starpharma Pty Ltd 2016-07-04
NCT02210689 A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women https://ClinicalTrials.gov/show/NCT02210689 Completed Actavis Inc. 2014-10-31
NCT02209519 Randomized Controlled Trial of Treatment of Male Partners of Women With BV https://ClinicalTrials.gov/show/NCT02209519 Completed University of Alabama at Birmingham 2019-03-31
NCT02150655 Study of the Microbiota, Metabolome, and Environmental Toxins in Relation to Reproductive Health in Rwandan Women https://ClinicalTrials.gov/show/NCT02150655 Completed Western University, Canada 2013-09-30
NCT02147899 A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT02147899 Completed Symbiomix Therapeutics 2014-10-31
NCT02139839 Exploratory Study to Evaluate the Effects of the Probiotics L. Rhamnosus GR-1 and L. Reuteri RC-14 https://ClinicalTrials.gov/show/NCT02139839 Completed Kimberly-Clark Corporation 2013-03-31
NCT01293643 A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077) https://ClinicalTrials.gov/show/NCT01293643 Completed Merck Sharp & Dohme Corp. 2011-01-31
NCT01993524 Supplementation of Standard Antibiotic Therapy With Oral Probiotics for Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT01993524 Completed IBSS Biomed S.A. 2012-02-29
NCT01800825 Clindamycin to Reduce Preterm Birth in a Low Resource Setting https://ClinicalTrials.gov/show/NCT01800825 Completed Christiana Care Health Services 2016-04-30
NCT01697683 Probiotic Therapy for the Reversal of Bacterial Vaginosis in Pregnancy https://ClinicalTrials.gov/show/NCT01697683 Completed Mount Sinai Hospital, Canada 2014-03-31
NCT01621399 Safety and Efficacy Study to Treat Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT01621399 Completed Medicis Global Service Corporation 2012-10-31
NCT01577537 A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT01577537 Completed Starpharma Pty Ltd 2012-10-05
NCT01577238 A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT01577238 Completed Starpharma Pty Ltd 2012-07-20
NCT01471457 Trial of Trimosan Gel Effect on Pessary-associated Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT01471457 Completed University of New Mexico 2014-09-30
NCT01450462 Vitamin D and Sexual Health https://ClinicalTrials.gov/show/NCT01450462 Completed Ohio State University 2013-01-31
NCT01437722 Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV) https://ClinicalTrials.gov/show/NCT01437722 Completed Starpharma Pty Ltd 2012-12-31
NCT01347632 Study of How Bacterial Vaginosis and Its Treatment Affects Cervical and Vaginal Tissue https://ClinicalTrials.gov/show/NCT01347632 Completed CONRAD 2011-12-31
NCT04329338 Effects of Lactobacillus Pentosus KCA1 on the Gut and Vaginal Microbiome of Women With Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT04329338 Completed Nnamdi Azikiwe University 2019-09-20
NCT04189744 The ASPIRE Trial - Aiming for Safe Pregnancies by Reducing Malaria and Infections of the Reproductive Tract https://ClinicalTrials.gov/show/NCT04189744 Recruiting London School of Hygiene and Tropical Medicine 2022-05-06
NCT04171947 Vaginal Ovule With Flavonoid Tea Extract for the Correction of Imbalance in the Vaginal Environment https://ClinicalTrials.gov/show/NCT04171947 Completed Value Outcomes Ltd. 2018-05-09
NCT04046900 Modifying Organisms Transvaginally in Females https://ClinicalTrials.gov/show/NCT04046900 Recruiting Massachusetts General Hospital 2021-07-31
NCT03954990 Treatment of Bacterial Vaginosis Prior to Active Labor and Infectious Morbidity https://ClinicalTrials.gov/show/NCT03954990 Recruiting The University of Texas Medical Branch, Galveston 2021-06-01
NCT03943823 Postmenopausal Pessary Users: Estrogen Versus Trimosan https://ClinicalTrials.gov/show/NCT03943823 Recruiting The University of Texas Health Science Center, Houston 2022-05-01
NCT03937869 Evaluate the Safety of a Single Oral Dose of Solosecâ„¢ (Secnidazole) 2g for the Treatment of Adolescent Girls With BV https://ClinicalTrials.gov/show/NCT03937869 Recruiting Lupin Research Inc 2020-12-31
NCT03930745 Suppression Of Bacterial Vaginosis (BV) [SUBVert] https://ClinicalTrials.gov/show/NCT03930745 Recruiting National Institute of Allergy and Infectious Diseases (NIAID) 2020-07-01
NCT03894813 Probiotics as Adjuvant Treatment for Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT03894813 Recruiting Peking University Shenzhen Hospital 2020-12-30
NCT03878511 Therapeutic Lactose to Support Vaginal Microbiota https://ClinicalTrials.gov/show/NCT03878511 Completed Regionshospitalet Viborg, Skive 2013-03-01
NCT03839875 Evaluation of Efficacy and Safety of Gynomax® XL Ovule https://ClinicalTrials.gov/show/NCT03839875 Completed Exeltis Turkey 2019-08-09
NCT03837015 Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women https://ClinicalTrials.gov/show/NCT03837015 Recruiting McMaster University 2020-12-31
NCT03762083 Clinical Performance of a Vaginal Pessary (pHyph) in Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT03762083 Completed Gedea Biotech AB 2019-10-22
NCT03601429 Dietary Supplementation of Lactogyn in Women With Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT03601429 Completed Vesale Pharmaceutica 2018-08-31
NCT03446443 Honghe Fujie Lotion for the Treatment of Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT03446443 Recruiting Dongfang Hospital Beijing University of Chinese Medicine 2019-07-31
NCT01258556 The Impact of Probiotic Bacteria on the Efficacy of Anti-retroviral Therapy and Recurrence of Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT01258556 Completed Lawson Health Research Institute 2010-07-31
NCT01245322 Treatment of Bacterial Vaginosis Combined With Human Lactobacilli https://ClinicalTrials.gov/show/NCT01245322 Completed Skaraborg Hospital 2014-10-31
NCT01230814 Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women https://ClinicalTrials.gov/show/NCT01230814 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2013-08-31
NCT01201057 Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV) https://ClinicalTrials.gov/show/NCT01201057 Completed Starpharma Pty Ltd 2011-03-31
NCT01160796 Lcr35® for Bacterial Vaginosis Prevention https://ClinicalTrials.gov/show/NCT01160796 Completed Laboratoires Lyocentre 2011-05-31
NCT01125410 Comparative Study of Efficacy of 10 mg Dequalinium Chloride (Fluomizin) in the Local Treatment of Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT01125410 Completed Medinova AG 2008-07-31
NCT01055106 Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT01055106 Completed Graceway Pharmaceuticals, LLC 2010-04-30
NCT01020396 Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT01020396 Completed Teva Pharmaceuticals USA 2003-03-31
NCT04414527 Effects of Video-based Health Education on Maternal and Child Health in Ethiopia https://ClinicalTrials.gov/show/NCT04414527 Recruiting University Ghent 2021-12-31
NCT02641717 Validity of Patient-Collected Wet Mounts https://ClinicalTrials.gov/show/NCT02641717 Completed The University of Texas Health Science Center at San Antonio 2016-07-31
NCT03211156 Treatment of Gardnerella Vaginalis Vaginal Colonization With Amoxicillin https://ClinicalTrials.gov/show/NCT03211156 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2019-08-22
NCT00720291 Inflammation and Treatment of Bacterial Vaginosis Near Term https://ClinicalTrials.gov/show/NCT00720291 Completed Medical University of South Carolina 2010-11-23
NCT00667368 Bacterial Vaginosis Home Screening to Prevent STDs https://ClinicalTrials.gov/show/NCT00667368 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2014-12-31
NCT00642980 Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT00642980 Completed University Hospital, Lille 2011-06-30
NCT00635622 Safety and Efficacy Study of Lactobacillus Administered Vaginally in Women With Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT00635622 Completed Osel, Inc. 2009-01-31
NCT00556179 Lactoserum (Dermacyd Femina®) and Prevention of Recurrence of Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT00556179 Completed Sanofi 2008-12-31
NCT00545181 Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial https://ClinicalTrials.gov/show/NCT00545181 Completed Indiana University 2009-07-31
NCT00542074 Bacterial Vaginosis; A Randomized Trial to Reduce Recurrence https://ClinicalTrials.gov/show/NCT00542074 Completed University of Washington NA
NCT00537576 Safety Study of Lactobacillus Administered Vaginally to Healthy Women https://ClinicalTrials.gov/show/NCT00537576 Completed Osel, Inc. 2008-03-31
NCT00510614 Tinidazole for Recurrent Bacterial Vaginosis: A Pilot Study https://ClinicalTrials.gov/show/NCT00510614 Completed University of Pittsburgh 2009-09-30
NCT00484653 Identification and Impact of Vaginal Flora Anomalies Among Pregnant Woman https://ClinicalTrials.gov/show/NCT00484653 Completed Assistance Publique Hopitaux De Marseille 2013-07-31
NCT00464542 Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study https://ClinicalTrials.gov/show/NCT00464542 Completed University of Pittsburgh 2010-03-31
NCT00799500 Bacterial Vaginosis in Pregnancy: Detection by Weekly Vaginal pH Testing https://ClinicalTrials.gov/show/NCT00799500 Completed Hospital Clinic of Barcelona 2010-12-31
NCT00334633 Treatment of Bacterial Vaginosis (BV) With Tinidazole https://ClinicalTrials.gov/show/NCT00334633 Completed University of Alabama at Birmingham 2009-12-31
NCT00324818 Treatment of Bacterial Vaginosis https://ClinicalTrials.gov/show/NCT00324818 Completed University of Alabama at Birmingham 2006-05-31
NCT00318253 The Effects of Cranberry Juice on Bacterial Adhesion https://ClinicalTrials.gov/show/NCT00318253 Completed Lawson Health Research Institute 2006-08-31
NCT00313131 Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments https://ClinicalTrials.gov/show/NCT00313131 Completed Université de Sherbrooke NA
NCT00799214 BASIC (Boric Acid, Alternate Solution for Intravaginal Colonization) Study https://ClinicalTrials.gov/show/NCT00799214 Completed University of British Columbia 2015-11-30
NCT00229216 Treatment of Bacterial Vaginosis With Oral Tinidazole https://ClinicalTrials.gov/show/NCT00229216 Completed Mission Pharmacal 2007-06-30
NCT00140764 Intravaginal Treatment of Disturbances of Vaginal Flora Among HIV Infected and Uninfected Women in Malawi https://ClinicalTrials.gov/show/NCT00140764 Completed Johns Hopkins Bloomberg School of Public Health NA
NCT00153517 Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy https://ClinicalTrials.gov/show/NCT00153517 Completed Centers for Disease Control and Prevention NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03303859 Bacterial Vaginosis Carriage in Early Pregnancy and Preterm Delivery in Martinique, F.W.I https://ClinicalTrials.gov/show/NCT03303859 Completed University Hospital Center of Martinique 2016-06-26
NCT03045809 Women’s Improvement of Sexual Health (WISH) Demonstration Project https://ClinicalTrials.gov/show/NCT03045809 Completed University of Liverpool 2017-03-14
NCT02348463 Treatment of Bacterial Vaginosis in Early Pregnancy in Skaraborg and the Effect on Spontaneous Preterm Delivery https://ClinicalTrials.gov/show/NCT02348463 Completed Skaraborg Hospital 2013-12-31
NCT02272231 Pathogenesis of Bacterial Vaginosis in Women Who Have Sex With Women https://ClinicalTrials.gov/show/NCT02272231 Completed University of Alabama at Birmingham 2019-01-31
NCT02203942 Comparing NAAT Testing to Standard Methods for the Diagnosis of Vaginitis https://ClinicalTrials.gov/show/NCT02203942 Completed University of Pittsburgh 2015-06-30
NCT02042352 PNA FISH, PCR and Gram Staining for Detection of Bacterial Vaginosis - a Comparative Clinical Study in a Danish IVF Setting https://ClinicalTrials.gov/show/NCT02042352 Completed Regionshospitalet Viborg, Skive 2015-02-28
NCT01335373 Observational Program Neo-Penotran® Forte https://ClinicalTrials.gov/show/NCT01335373 Completed Bayer 2011-12-31
NCT04287504 Point-of-care Tests for Bacterial Vaginosis and Candidosis https://ClinicalTrials.gov/show/NCT04287504 Recruiting Medical University of Vienna 2020-12-31
NCT04067557 Diagnosis of Bacterial Vaginosis Comparing Modified Hay/Ison With Molecular Diagnosis https://ClinicalTrials.gov/show/NCT04067557 Completed Skaraborg Hospital 2013-05-01
NCT04057482 Treatment of BV With Donaxyl and a Molecular Test of Cure https://ClinicalTrials.gov/show/NCT04057482 Completed Skaraborg Hospital 2017-12-31
NCT00802386 Bacterial Vaginosis Screening at IUD Insertion https://ClinicalTrials.gov/show/NCT00802386 Completed St. Michael’s Hospital, Toronto 2009-03-31
NCT00682851 A Validation Study of Genzyme Diagnostics OSOM Trichomonas Rapid Test and BVBlue Test https://ClinicalTrials.gov/show/NCT00682851 Completed University of Pittsburgh 2009-04-30
NCT00070746 Perinatal Infections in Pakistan https://ClinicalTrials.gov/show/NCT00070746 Completed NICHD Global Network for Women’s and Children’s Health NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02295579 Will Lactobacillus Increase Cure Rate After Treatment of Bacterial Vaginosis and Chronic Vulvovaginal Candida https://ClinicalTrials.gov/show/NCT02295579 Completed Skaraborg Hospital 2015-06-30
NCT01829204 Prospective Data Bank Creation to Study Vaginal Conditions https://ClinicalTrials.gov/show/NCT01829204 Recruiting Texas Tech University Health Sciences Center 2020-07-31